XIAP and neoplasm: Therapeutically, we provide experimental evidence that combinatorial treatment strategies with TRAIL and SMAC mimetics or XIAP-targeting drugs overcome the apoptosis-hampering conditions imposed by the hypoxic tumor microenvironment.